COVID-19 Vaccines: Lost Placebo Control Could Mean Lost Approval, US FDA Officials Say

Getting an EUA is not a reason to vaccinate all placebo patients, US FDA officials write in NEJM article.

3D_Coronavirus
FDA officials said in a NEJM article that curtailing their requirement for a median of two months of safety follow-up could undermine its scientific credibility. • Source: Shutterstock

US Food and Drug Administration officials expect coronavirus vaccine trials to maintain placebo controls even after an emergency use authorization to ensure multiple candidates still can be cleared.

In a New England Journal of Medicine article published on 16 October, Philip Krause and Marion Gruber, deputy director...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet